Brigitte Smith
Director
Pharmaceutical sciences
Elastagen
Australia
Biography
Brigitte Smith has twenty years experience in venture capital, business strategy and start-up company operations. Brigitte has been investing and managing investments for GBS’s $450m of life science specialised venture capital funds since 1998. Brigitte is on the board of GBS portfolio companies AirXpanders Inc, Elastagen Pty Ltd, Endoluminal Systems Pty Ltd, Neurovance Inc, and Vivive Inc. Brigitte was the founding investor and chair of Pharmaxis Pty Ltd. Prior to founding GBS Brigitte worked in the US and Australia in operating roles with early stage technology based companies, and at Bain & Company as a strategic management consultant. Ms Smith has a B. Chem Eng (Honours) from the University of Melbourne, and as a Fulbright Scholar completed a MBA (Honours) from the Harvard Business School and a MALD from the Fletcher School of Law and Diplomacy, both in Boston, USA. Ms Smith has also been an adjunct lecturer in Entrepreneurial Finance at Melbourne Business School.
Research Interest
Pharmaceutical sciences